This Article Full Text Full Text (PDF) All Versions of this Article: M1908v1 13/2/180    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Matheny, M. E. Articles by Resnic, F. S. Search for Related Content PubMed PubMed Citation Articles by Matheny, M. E. Articles by Resnic, F. S.

Monitoring Device Safety in Interventional Cardiology

Affiliations of the authors: Decision Systems Group, Department of Radiology, Harvard Medical School, Boston, MA (MEM, LOM, FSR), Harvard-MIT Division of Health Sciences & Technology, Massachusetts Institute of Technology, Cambridge, MA (MEM, LOM, FSR).

Correspondence and reprints: Frederic S. Resnic, MD, MS, Brigham & Women's Hospital, 75 Francis Street, Boston, MA 02115; e-mail: <mmatheny{at}dsg.harvard.edu>, Michael E. Matheny, MD; e-mail: <fresnic{at}partners.org>.

Received for publication: 07/07/05; accepted for publication: 10/16/05.

Objective: A variety of postmarketing surveillance strategies to monitor the safety of medical devices have been supported by the U.S. Food and Drug Administration, but there are few systems to automate surveillance. Our objective was to develop a system to perform real-time monitoring of safety data using a variety of process control techniques.

Design: The Web-based Data Extraction and Longitudinal Time Analysis (DELTA) system imports clinical data in real-time from an electronic database and generates alerts for potentially unsafe devices or procedures. The statistical techniques used are statistical process control (SPC), logistic regression (LR), and Bayesian updating statistics (BUS).

Measurements: We selected in-patient mortality following implantation of the Cypher drug-eluting coronary stent to evaluate our system. Data from the University of Michigan Consortium Bare-Metal Stent Study was used to calculate the event rate alerting boundaries. Data analysis was performed on local catheterization data from Brigham and Women's Hospital from July 1, 2003, shortly after the Cypher release, to December 31, 2004, including 2,270 cases with 27 observed deaths.

Results: The single-stratum SPC had alerts in months 4 and 10. The multistrata SPC had alerts in months 5, 10, and 18 in the moderate-risk stratum, and months 1, 4, 7, and 10 in the high-risk stratum. The only cumulative alerts were in the first month for the high-risk stratum of the multistrata SPC. The LR method showed no monthly or cumulative alerts. The BUS method showed an alert in the first month for the high-risk stratum.

Conclusion: The system performed adequately within the Brigham and Women's Hospital Intranet environment based on the design goals. All three cumulative methods agreed that the overall observed event rates were not significantly higher for the new medical device than for a closely related medical device and were consistent with the observation that the initial concerns about this device dissipated as more data accumulated.